244PImmune infiltrate composition across intrinsic subtypes in hormone receptor (HR)+/HER2- early breast cancer (BC) enrolled in the prospective LETLOB trial
Griguolo, G, Dieci, M V, Paré, L, Miglietta, F, Generali, D G, Frassoldati, A, Bisagni, G, Piacentini, F, Tagliafico, E, Cagossi, K, Ficarra, G, Prat, A, Conte, P F, Guarneri, VVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz240.068
Date:
October, 2019
File:
PDF, 77 KB
2019